Azienda Ospedaliera di Padova

2 trials 2 recruiting Academic / non-commercial

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Countries active

2 Unique IMPs

N/A Results reported

Phase II

Top IMPs

CLENBUTEROL HYDROCHLORIDE 1 ZANUBRUTINIB 1

All trials

2 total

Zanubritnib and anti-MAG neuropathy Recruiting

2025-523091-23-00 Phase II 1 country ZANUBRUTINIB
A Placebo-controlled Study to Evaluate the Efficacy and Safety of Clenbuterol in Patients with Spinal and Bulbar Muscular Atrophy (SBMA) Recruiting

2024-516563-86-00 Phase II 1 country CLENBUTEROL HYDROCHLORIDE

Showing 1–2 of 2 trials

← All sponsors A–Z